Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q3 2021 Earnings Conference Call November 1, 2021 4:30 PM ET Company Participants Todd Tushla - Vice President, Investor Relations Kevin Gorman - Chief Executive Officer and Director Matt Abernethy - Chief Financial Officer Eric Benevich - Chief Commercial Officer Eiry Roberts - Chief Medical Officer Conference Call Participants Neena Garg - Citi Paul Matteis - Stifel Carter Gould - Barclays Tazeen Ahmad - Bank of America Phil Nadeau - Cowen Company Anupam Rama - J ...

| --- | --- | --- | --- | |----------------|------------------------------------------------------|-------|--------------------------------| | | | | | | | Advancing Life-Changing Discoveries in Neuroscience | | Q2 2021 Corporate Presentation | | neurocrine.com | | | August 3, 2021 Nasdaq: NBIX | Safe Harbor Statement and Non-GAAP Financial Measures In addition to historical facts, this presentation contains forward-looking statements that involve a number of risks and uncertainties. These statements include ...

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q2 2021 Results Conference Call August 3, 2021 4:30 PM ET Company Participants Todd Tushla - VP, IR Kevin Gorman - CEO Matt Abernethy - CFO Eiry Roberts - Chief Medical Officer Eric Benevich - Chief Commercial Officer Kyle Gano - Chief Business Development and Strategy Officer Conference Call Participants Tazeen Ahmad - Bank of America Phil Nadeau - The Cowen Company Paul Matteis - Stifel Brian Abrahams - RBC Capital Markets Brian Skorney - Baird Jay Olson - Oppenh ...

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q1 2021 Earnings Conference Call May 5, 2021 4:30 PM ET Company Participants Todd Tushla - Vice President, Investor Relations Kevin Gorman - Chief Executive Officer Matt Abernethy - Chief Financial Officer Eiry Roberts - Chief Medical Officer Eric Benevich - Chief Commercial Officer Conference Call Participants Brian Abrahams - RBC Capital Paul Matteis - Stifel Phil Nadeau - Cowen & Company Brian Skorney - Baird Josh Schimmer - Evercore ISI Neena Bitritto-Garg - Ci ...

| --- | --- | --- | --- | --- | |----------------|------------------------------------------------------|-------|-------|--------------------------------------------| | | | | | | | | Advancing Life-Changing Discoveries in Neuroscience | | | Q1 2021 Corporate Presentation May 5, 2021 | | neurocrine.com | | | | Nasdaq: NBIX | Safe Harbor Statement and Non-GAAP Financial Measures In addition to historical facts, this presentation contains forward-looking statements that involve a number of risks and uncertaint ...

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q4 2020 Earnings Conference Call February 4, 2021 4:30 PM ET Company Participants Todd Tushla - Vice President, Investor Relations Kevin Gorman - Chief Executive Officer Matt Abernethy - Chief Financial Officer Eiry Roberts - Chief Medical Officer Eric Benevich - Chief Commercial Officer Kyle Gano - Chief Business Development and Strategy Officer Conference Call Participants Biren Amin - Jefferies Paul Matteis - Stifel Tazeen Ahmad - Bank of America Josh Schimmer - ...

Neurocrine® Advancing Life-Changing Discoveries in Neuroscience neurocrine.com Q4 2020 / Year-End Corporate Presentation February 4, 2021 Nasdaq: NBIX Safe Harbor Statement and Non-GAAP Financial Measures In addition to historical facts, this presentation contains forward-looking statements that involve a number of risks and uncertainties. These statements include, but are not limited to, statements related to: the benefits to be derived from our products and product candidates; the value our products and/o ...

| --- | --- | --- | --- | |----------------|------------------------------------------------------|-------|-------------------------------------------------| | | | | | | | Advancing Life-Changing Discoveries in Neuroscience | | Q3 2020 Corporate Presentation November 9, 2020 | | neurocrine.com | | | Nasdaq: NBIX | Safe Harbor Statement and Non-GAAP Financial Measures In addition to historical facts, this presentation contains forward-looking statements that involve a number of risks and uncertainties. These ...

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q3 2020 Earnings Conference Call November 9, 2020 4:30 PM ET Company Participants Todd Tushla - Vice President, Investor Relations Kevin Gorman - Chief Executive Officer Matthew Abernethy - Chief Financial Officer Eric Benevich - Chief Commercial Officer Eiry Roberts - Chief Medical Officer Conference Call Participants Josh Schimmer - Evercore ISI Tazeen Ahmad - Bank of America Paul Matteis - Stifel Biren Amin - Jefferies Phil Nadeau - Cowen & Company Brian Skorney ...

Neurocrine® Advancing Life-Changing Discoveries in Neuroscience Q2 2020 Corporate Presentation August 3, 2020 Nasdaq: NBIX neurocrine.com Safe Harbor Statement and Non-GAAP Financial Measures In addition to historical facts, this presentation contains forward-looking statements that involve a number of risks and uncertainties. These statements include, but are not limited to, statements related to: the benefits to be derived from our products and product candidates; the value our products and/or our product ...